메뉴 건너뛰기




Volumn 56, Issue 21, 2013, Pages 8484-8496

Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; 3 (1 ((1,1' BIPHENYL) 4 YL)ETHYL) 5 METHOXY 1,3,4 OXADIAZOL 2(3H) ONE; 3 (1 (4 (DIPHENYLAMINO)PHENYL)ETHYL) 5 METHOXY 1,3,4 OXADIAZOL 2(3H) ONE; 3 (1 (4 ISOBUTYLPHENYL)ETHYL) 5 METHOXY 1,3,4 OXADIAZOL 2(3H) ONE; ACYLGLYCEROL LIPASE; CAY 10435; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; JZP 327A; METHYL GROUP; PF 750; PROSTAGLANDIN SYNTHASE; RECOMBINANT ENZYME; SERINE DEHYDRATASE; UNCLASSIFIED DRUG;

EID: 84887858786     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm400923s     Document Type: Article
Times cited : (57)

References (78)
  • 2
    • 0029904838 scopus 로고    scopus 로고
    • Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
    • Cravatt, B. F.; Giang, D. K.; Mayfield, S. P.; Boger, D. L.; Lerner, R. A.; Gilula, N. B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 1996, 384, 83-87
    • (1996) Nature , vol.384 , pp. 83-87
    • Cravatt, B.F.1    Giang, D.K.2    Mayfield, S.P.3    Boger, D.L.4    Lerner, R.A.5    Gilula, N.B.6
  • 3
    • 21344432777 scopus 로고    scopus 로고
    • The endocannabinoid system: A drug discovery perspective
    • Piomelli, D. The endocannabinoid system: a drug discovery perspective Curr. Opin. Invest. Drugs (Thomson Sci.) 2005, 6, 672-679
    • (2005) Curr. Opin. Invest. Drugs (Thomson Sci.) , vol.6 , pp. 672-679
    • Piomelli, D.1
  • 7
    • 79955383220 scopus 로고    scopus 로고
    • Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: Orally active, long-acting analgesics
    • Ezzili, C.; Mileni, M.; McGlinchey, N.; Long, J. Z.; Kinsey, S. G.; Hochstatter, D. G.; Stevens, R. C.; Lichtman, A. H.; Cravatt, B. F.; Bilsky, E. J.; Boger, D. L. Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics J. Med. Chem. 2011, 54, 2805-2822
    • (2011) J. Med. Chem. , vol.54 , pp. 2805-2822
    • Ezzili, C.1    Mileni, M.2    McGlinchey, N.3    Long, J.Z.4    Kinsey, S.G.5    Hochstatter, D.G.6    Stevens, R.C.7    Lichtman, A.H.8    Cravatt, B.F.9    Bilsky, E.J.10    Boger, D.L.11
  • 11
    • 22244484464 scopus 로고    scopus 로고
    • Structure and function of fatty acid amide hydrolase
    • McKinney, M. K.; Cravatt, B. F. Structure and function of fatty acid amide hydrolase Annu. Rev. Biochem. 2005, 74, 411-432
    • (2005) Annu. Rev. Biochem. , vol.74 , pp. 411-432
    • McKinney, M.K.1    Cravatt, B.F.2
  • 12
    • 84876745053 scopus 로고    scopus 로고
    • Latest advances in the discovery of fatty acid amide hydrolase inhibitors
    • Bisogno, T.; Maccarrone, M. Latest advances in the discovery of fatty acid amide hydrolase inhibitors Expert Opin. Drug Discovery 2013, 8, 509-522
    • (2013) Expert Opin. Drug Discovery , vol.8 , pp. 509-522
    • Bisogno, T.1    MacCarrone, M.2
  • 13
    • 84880950751 scopus 로고    scopus 로고
    • Chemical probes of endocannabinoid metabolism
    • Blankman, J. L.; Cravatt, B. F. Chemical probes of endocannabinoid metabolism Pharmacol. Rev. 2013, 65, 849-871
    • (2013) Pharmacol. Rev. , vol.65 , pp. 849-871
    • Blankman, J.L.1    Cravatt, B.F.2
  • 14
    • 84857408437 scopus 로고    scopus 로고
    • Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis
    • Feledziak, M.; Lambert, D. M.; Marchand-Brynaert, J.; Muccioli, G. G. Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis Recent Pat. CNS Drug Discovery 2012, 7, 49-70
    • (2012) Recent Pat. CNS Drug Discovery , vol.7 , pp. 49-70
    • Feledziak, M.1    Lambert, D.M.2    Marchand-Brynaert, J.3    Muccioli, G.G.4
  • 15
    • 79960901769 scopus 로고    scopus 로고
    • The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)
    • Otrubova, K.; Ezzili, C.; Boger, D. L. The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH) Bioorg. Med. Chem. Lett. 2011, 21, 4674-4685
    • (2011) Bioorg. Med. Chem. Lett. , vol.21 , pp. 4674-4685
    • Otrubova, K.1    Ezzili, C.2    Boger, D.L.3
  • 16
    • 74549185125 scopus 로고    scopus 로고
    • FAAH and MAGL inhibitors: Therapeutic opportunities from regulating endocannabinoid levels
    • Petrosino, S.; Di Marzo, V. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels Curr. Opin. Invest. Drugs (BioMed Cent.) 2010, 11, 51-62
    • (2010) Curr. Opin. Invest. Drugs (BioMed Cent.) , vol.11 , pp. 51-62
    • Petrosino, S.1    Di Marzo, V.2
  • 17
    • 40349114245 scopus 로고    scopus 로고
    • Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors
    • Vandevoorde, S. Overview of the chemical families of fatty acid amide hydrolase and monoacylglycerol lipase inhibitors Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) 2008, 8, 247-267
    • (2008) Curr. Top. Med. Chem. (Sharjah, United Arab Emirates) , vol.8 , pp. 247-267
    • Vandevoorde, S.1
  • 18
    • 57349170752 scopus 로고    scopus 로고
    • Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors
    • Seierstad, M.; Breitenbucher, J. G. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors J. Med. Chem. 2008, 51, 7327-7343
    • (2008) J. Med. Chem. , vol.51 , pp. 7327-7343
    • Seierstad, M.1    Breitenbucher, J.G.2
  • 19
    • 4744354729 scopus 로고    scopus 로고
    • Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: Synthesis, quantitative structure-activity relationships, and molecular modeling studies
    • Mor, M.; Rivara, S.; Lodola, A.; Plazzi, P. V.; Tarzia, G.; Duranti, A.; Tontini, A.; Piersanti, G.; Kathuria, S.; Piomelli, D. Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies J. Med. Chem. 2004, 47, 4998-5008
    • (2004) J. Med. Chem. , vol.47 , pp. 4998-5008
    • Mor, M.1    Rivara, S.2    Lodola, A.3    Plazzi, P.V.4    Tarzia, G.5    Duranti, A.6    Tontini, A.7    Piersanti, G.8    Kathuria, S.9    Piomelli, D.10
  • 26
    • 84878526504 scopus 로고    scopus 로고
    • 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling
    • Käsnänen, H.; Minkkilä, A.; Taupila, S.; Patel, J. Z.; Parkkari, T.; Lahtela-Kakkonen, M.; Saario, S. M.; Nevalainen, T.; Poso, A. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling Eur. J. Pharm. Sci. 2013, 49, 423-433
    • (2013) Eur. J. Pharm. Sci. , vol.49 , pp. 423-433
    • Käsnänen, H.1    Minkkilä, A.2    Taupila, S.3    Patel, J.Z.4    Parkkari, T.5    Lahtela-Kakkonen, M.6    Saario, S.M.7    Nevalainen, T.8    Poso, A.9
  • 27
    • 80052352965 scopus 로고    scopus 로고
    • Design, synthesis, and structure-activity relationships of 1,3,4-oxadiazol-2(3 H)-ones as novel FAAH inhibitors
    • Kiss, L. E.; Ferreira, H. S.; Beliaev, A.; Torrão, L.; Bonifáciob, M. J.; Learmonth, D. A. Design, synthesis, and structure-activity relationships of 1,3,4-oxadiazol-2(3 H)-ones as novel FAAH inhibitors Med. Chem. Commun. 2011, 2, 889-894
    • (2011) Med. Chem. Commun. , vol.2 , pp. 889-894
    • Kiss, L.E.1    Ferreira, H.S.2    Beliaev, A.3    Torrão, L.4    Bonifáciob, M.J.5    Learmonth, D.A.6
  • 28
    • 68249100483 scopus 로고    scopus 로고
    • Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid
    • Prusakiewicz, J. J.; Duggan, K. C.; Rouzer, C. A.; Marnett, L. J. Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid Biochemistry 2009, 48, 7353-7355
    • (2009) Biochemistry , vol.48 , pp. 7353-7355
    • Prusakiewicz, J.J.1    Duggan, K.C.2    Rouzer, C.A.3    Marnett, L.J.4
  • 30
    • 84874184618 scopus 로고    scopus 로고
    • Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide
    • Fowler, C. J.; Björklund, E.; Lichtman, A. H.; Naidu, P. S.; Congiu, C.; Onnis, V. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide J. Enzyme Inhib. Med. Chem. 2013, 28, 172-182
    • (2013) J. Enzyme Inhib. Med. Chem. , vol.28 , pp. 172-182
    • Fowler, C.J.1    Björklund, E.2    Lichtman, A.H.3    Naidu, P.S.4    Congiu, C.5    Onnis, V.6
  • 31
    • 0030730417 scopus 로고    scopus 로고
    • Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship
    • Fowler, C. J.; Tiger, G.; Stenström, A. Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship J. Pharmacol. Exp. Ther. 1997, 283, 729-734
    • (1997) J. Pharmacol. Exp. Ther. , vol.283 , pp. 729-734
    • Fowler, C.J.1    Tiger, G.2    Stenström, A.3
  • 32
    • 0037320223 scopus 로고    scopus 로고
    • Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner
    • Fowler, C. J.; Holt, S.; Tiger, G. Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner J. Enzyme Inhib. Med. Chem. 2003, 18, 55-58
    • (2003) J. Enzyme Inhib. Med. Chem. , vol.18 , pp. 55-58
    • Fowler, C.J.1    Holt, S.2    Tiger, G.3
  • 35
    • 84865277383 scopus 로고    scopus 로고
    • NSAIDs: Endocannabinoid stimulating anti-inflammatory drugs?
    • Fowler, C. J. NSAIDs: endocannabinoid stimulating anti-inflammatory drugs? Trends Pharmacol. Sci. 2012, 33, 468-473
    • (2012) Trends Pharmacol. Sci. , vol.33 , pp. 468-473
    • Fowler, C.J.1
  • 40
    • 84863110189 scopus 로고    scopus 로고
    • Synthesis and pharmacological evaluation of 2,4- dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors
    • Kapanda, C. N.; Masquelier, J.; Labar, G.; Muccioli, G. G.; Poupaert, J. H.; Lambert, D. M. Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors J. Med. Chem. 2012, 55, 5774-5783
    • (2012) J. Med. Chem. , vol.55 , pp. 5774-5783
    • Kapanda, C.N.1    Masquelier, J.2    Labar, G.3    Muccioli, G.G.4    Poupaert, J.H.5    Lambert, D.M.6
  • 41
    • 77649198453 scopus 로고    scopus 로고
    • Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases
    • Long, J. Z.; Jin, X.; Adibekian, A.; Li, W.; Cravatt, B. F. Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases J. Med. Chem. 2010, 53, 1830-1842
    • (2010) J. Med. Chem. , vol.53 , pp. 1830-1842
    • Long, J.Z.1    Jin, X.2    Adibekian, A.3    Li, W.4    Cravatt, B.F.5
  • 46
    • 34547789923 scopus 로고    scopus 로고
    • A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases
    • Li, W.; Blankman, J. L.; Cravatt, B. F. A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases J. Am. Chem. Soc. 2007, 129, 9594-9595
    • (2007) J. Am. Chem. Soc. , vol.129 , pp. 9594-9595
    • Li, W.1    Blankman, J.L.2    Cravatt, B.F.3
  • 47
    • 84867339289 scopus 로고    scopus 로고
    • Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)
    • Navia-Paldanius, D.; Savinainen, J. R.; Laitinen, J. T. Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12) J. Lipid Res. 2012, 53, 2413-2424
    • (2012) J. Lipid Res. , vol.53 , pp. 2413-2424
    • Navia-Paldanius, D.1    Savinainen, J.R.2    Laitinen, J.T.3
  • 48
    • 0034986485 scopus 로고    scopus 로고
    • Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide
    • Day, T. A.; Rakhshan, F.; Deutsch, D. G.; Barker, E. L. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide Mol. Pharmacol. 2001, 59, 1369-1375
    • (2001) Mol. Pharmacol. , vol.59 , pp. 1369-1375
    • Day, T.A.1    Rakhshan, F.2    Deutsch, D.G.3    Barker, E.L.4
  • 49
    • 33646928180 scopus 로고    scopus 로고
    • Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase
    • Kaczocha, M.; Hermann, A.; Glaser, S. T.; Bojesen, I. N.; Deutsch, D. G. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase J. Biol. Chem. 2006, 281, 9066-9075
    • (2006) J. Biol. Chem. , vol.281 , pp. 9066-9075
    • Kaczocha, M.1    Hermann, A.2    Glaser, S.T.3    Bojesen, I.N.4    Deutsch, D.G.5
  • 50
    • 0034720298 scopus 로고    scopus 로고
    • Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol
    • Beltramo, M.; Piomelli, D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol NeuroReport 2000, 11, 1231-1235
    • (2000) NeuroReport , vol.11 , pp. 1231-1235
    • Beltramo, M.1    Piomelli, D.2
  • 51
    • 50649112791 scopus 로고    scopus 로고
    • Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
    • Fowler, C. J.; Ghafouri, N. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? Pharmacol. Res. 2008, 58, 72-76
    • (2008) Pharmacol. Res. , vol.58 , pp. 72-76
    • Fowler, C.J.1    Ghafouri, N.2
  • 52
    • 77954385220 scopus 로고    scopus 로고
    • Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: Discovery of a deacylating water molecule and insight into enzyme inactivation
    • Mileni, M.; Kamtekar, S.; Wood, D. C.; Benson, T. E.; Cravatt, B. F.; Stevens, R. C. Crystal structure of fatty acid amide hydrolase bound to the carbamate inhibitor URB597: discovery of a deacylating water molecule and insight into enzyme inactivation J. Mol. Biol. 2010, 400, 743-754
    • (2010) J. Mol. Biol. , vol.400 , pp. 743-754
    • Mileni, M.1    Kamtekar, S.2    Wood, D.C.3    Benson, T.E.4    Cravatt, B.F.5    Stevens, R.C.6
  • 53
    • 80052788690 scopus 로고    scopus 로고
    • Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure
    • Lodola, A.; Rivara, S.; Mor, M. Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure Adv. Protein Chem. Struct. Biol. 2011, 85, 1-26
    • (2011) Adv. Protein Chem. Struct. Biol. , vol.85 , pp. 1-26
    • Lodola, A.1    Rivara, S.2    Mor, M.3
  • 56
    • 80051509102 scopus 로고    scopus 로고
    • Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: Long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency
    • Tian, G.; Paschetto, K. A.; Gharahdaghi, F.; Gordon, E.; Wilkins, D. E.; Luo, X.; Scott, C. W. Mechanism of inhibition of fatty acid amide hydrolase by sulfonamide-containing benzothiazoles: long residence time derived from increased kinetic barrier and not exclusively from thermodynamic potency Biochemistry 2011, 50, 6867-6878
    • (2011) Biochemistry , vol.50 , pp. 6867-6878
    • Tian, G.1    Paschetto, K.A.2    Gharahdaghi, F.3    Gordon, E.4    Wilkins, D.E.5    Luo, X.6    Scott, C.W.7
  • 57
    • 84875754855 scopus 로고    scopus 로고
    • Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors
    • Lodola, A.; Capoferri, L.; Rivara, S.; Tarzia, G.; Piomelli, D.; Mulholland, A.; Mor, M. Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors J. Med. Chem. 2013, 56, 2500-2512
    • (2013) J. Med. Chem. , vol.56 , pp. 2500-2512
    • Lodola, A.1    Capoferri, L.2    Rivara, S.3    Tarzia, G.4    Piomelli, D.5    Mulholland, A.6    Mor, M.7
  • 60
    • 0141452964 scopus 로고    scopus 로고
    • WinGX suite for small-molecule single-crystal crystallography
    • Farrugia, L. J. WinGX suite for small-molecule single-crystal crystallography J. Appl. Crystallogr. 1999, 32, 837-838
    • (1999) J. Appl. Crystallogr. , vol.32 , pp. 837-838
    • Farrugia, L.J.1
  • 62
    • 38349137146 scopus 로고    scopus 로고
    • Determination of absolute structure using Bayesian statistics on bijvoet differences
    • Hooft, R. W. W.; Straver, L. H.; Spek, A. L. Determination of absolute structure using Bayesian statistics on bijvoet differences J. Appl. Crystallogr. 2008, 41, 96-103
    • (2008) J. Appl. Crystallogr. , vol.41 , pp. 96-103
    • Hooft, R.W.W.1    Straver, L.H.2    Spek, A.L.3
  • 64
    • 33746718652 scopus 로고    scopus 로고
    • Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system
    • Saario, S. M.; Poso, A.; Juvonen, R. O.; Järvinen, T.; Salo-Ahen, O. M. H. Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system J. Med. Chem. 2006, 49, 4650-4656
    • (2006) J. Med. Chem. , vol.49 , pp. 4650-4656
    • Saario, S.M.1    Poso, A.2    Juvonen, R.O.3    Järvinen, T.4    Salo-Ahen, O.M.H.5
  • 65
  • 66
    • 0027480087 scopus 로고
    • Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
    • Meade, E. A.; Smith, W. L.; DeWitt, D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J. Biol. Chem. 1993, 268, 6610-6614
    • (1993) J. Biol. Chem. , vol.268 , pp. 6610-6614
    • Meade, E.A.1    Smith, W.L.2    Dewitt, D.L.3
  • 67
    • 77949420579 scopus 로고    scopus 로고
    • Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors
    • Onnis, V.; Congiu, C.; Björklund, E.; Hempel, F.; Söderström, E.; Fowler, C. J. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors J. Med. Chem. 2010, 53, 2286-2298
    • (2010) J. Med. Chem. , vol.53 , pp. 2286-2298
    • Onnis, V.1    Congiu, C.2    Björklund, E.3    Hempel, F.4    Söderström, E.5    Fowler, C.J.6
  • 68
    • 84887974159 scopus 로고    scopus 로고
    • version 2.5; Schrödinger, LLC: New York, NY.
    • LigPrep, version 2.5; Schrödinger, LLC: New York, NY, 2012.
    • (2012) LigPrep
  • 69
    • 77956064328 scopus 로고    scopus 로고
    • version 2.3; Schrödinger, LLC: New York, NY.
    • Protein Preparation Wizard, Epik, version 2.3; Schrödinger, LLC: New York, NY, 2012.
    • (2012) Protein Preparation Wizard, Epik
  • 70
    • 84887920991 scopus 로고    scopus 로고
    • version 5.8; Schrödinger, LLC: New York, NY.
    • Impact, version 5.8; Schrödinger, LLC: New York, NY, 2012.
    • (2012) Impact
  • 71
    • 84887978408 scopus 로고    scopus 로고
    • version 3.1; Schrödinger, LLC: New York, NY.
    • Prime, version 3.1; Schrödinger, LLC: New York, NY, 2012.
    • (2012) Prime
  • 72
    • 84873407140 scopus 로고    scopus 로고
    • version 5.8; Schrödinger, LLC: New York, NY.
    • Induced Fit Docking Protocol, Glide, version 5.8; Schrödinger, LLC: New York, NY, 2012.
    • (2012) Induced Fit Docking Protocol, Glide
  • 73
    • 84887921834 scopus 로고    scopus 로고
    • version 3.1; Schrödinger, LLC: New York, NY.
    • Prime, version 3.1; Schrödinger, LLC: New York, NY, 2012.
    • (2012) Prime
  • 74
    • 84855757480 scopus 로고    scopus 로고
    • version 2012.10; Chemical Computing Group Inc. (1010 Sherbooke St. West, Suite No. 910, Montreal, QC, Canada, H3A 2R7).
    • Molecular Operating Environment (MOE), version 2012.10; Chemical Computing Group Inc. (1010 Sherbooke St. West, Suite No. 910, Montreal, QC, Canada, H3A 2R7), 2012.
    • (2012) Molecular Operating Environment (MOE)
  • 77
    • 84887966470 scopus 로고    scopus 로고
    • ArgusLab.
    • ArgusLab. http://www.arguslab.com/arguslab.com/ArgusLab.html.
  • 78
    • 4043162793 scopus 로고    scopus 로고
    • VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming
    • Pedretti, A.; Villa, L.; Vistoli, G. VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming J. Comput.-Aided Mol. Des. 2004, 18, 167-173
    • (2004) J. Comput.-Aided Mol. Des. , vol.18 , pp. 167-173
    • Pedretti, A.1    Villa, L.2    Vistoli, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.